A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
作者信息
Korn Thomas, Oukka Mohamed
机构信息
From Klinikum rechts der Isar, Department of Neurology, Technical University of Munich, and the Munich Cluster for Systems Neurology, Munich, Germany (T.K.); and the Department of Immunology, University of Washington, and the Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle (M.O.).
出版信息
N Engl J Med. 2017 Apr 27;376(17):1680-1681. doi: 10.1056/NEJMe1700720.
Abstract
摘要
相似文献
1
A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.疟疾抗性与多发性硬化症风险之间令人困惑的关联。
N Engl J Med. 2017 Apr 27;376(17):1680-1681. doi: 10.1056/NEJMe1700720.
2
Un-BAFFling gray matter pathology in multiple sclerosis.解析多发性硬化症中的灰质病理。
Sci Immunol. 2024 Apr 5;9(94):eadp4667. doi: 10.1126/sciimmunol.adp4667.
3
Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.一名铁和维生素D缺乏的尼日利亚患者，在先前治疗疟疾后出现类似多发性硬化症的诊断结果，作为一种并发症。
Metab Brain Dis. 2016 Feb;31(1):197-204. doi: 10.1007/s11011-015-9788-4. Epub 2016 Jan 8.
4
Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part I.多发性硬化症是由疟原虫的隐匿感染引起的吗？一种历史流行病学方法：第一部分。
Med Hypotheses. 2001 Sep;57(3):280-91. doi: 10.1054/mehy.2001.1276.
5
Multiple sclerosis - the remarkable story of a baffling disease.多发性硬化症——一种令人费解疾病的非凡故事。
Rev Neurosci. 2019 Jul 26;30(5):511-526. doi: 10.1515/revneuro-2018-0074.
6
Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part II.多发性硬化症是由疟原虫的隐匿感染引起的吗？一种历史流行病学方法：第二部分。
Med Hypotheses. 2001 Sep;57(3):292-301. doi: 10.1054/mehy.2001.1277.
7
Hygiene hypothesis: innate immunity, malaria and multiple sclerosis.卫生假说：先天免疫、疟疾与多发性硬化症
Med Hypotheses. 2008;70(4):819-25. doi: 10.1016/j.mehy.2006.10.069. Epub 2007 Sep 21.
8
Case report of an atypical presentation of falciparum malaria.恶性疟原虫疟疾非典型表现的病例报告。
East Afr Med J. 1987 Jan;64(1):88-9.
9
Overexpression of the Cytokine BAFF and Autoimmunity Risk.细胞因子BAFF的过表达与自身免疫风险
N Engl J Med. 2017 Apr 27;376(17):1615-1626. doi: 10.1056/NEJMoa1610528.
10
Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia.撒丁岛中部地区祖先单倍型HLA A30B18DR3与多发性硬化症之间的关联
Genet Epidemiol. 2001 Feb;20(2):271-83. doi: 10.1002/1098-2272(200102)20:2<271::AID-GEPI9>3.0.CO;2-L.
引用本文的文献
1
Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases.弥漫性结缔组织病患者水痘-带状疱疹病毒体液免疫状态的评估。
Front Med (Lausanne). 2024 Sep 5;11:1470068. doi: 10.3389/fmed.2024.1470068. eCollection 2024.
2
Epstein-Barr virus, interleukin-10 and multiple sclerosis: A ménage à trois.爱泼斯坦-巴尔病毒、白细胞介素-10 和多发性硬化症：三者之间的关系。
Front Immunol. 2022 Oct 7;13:1028972. doi: 10.3389/fimmu.2022.1028972. eCollection 2022.
3
Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls.与健康对照相比，系统性红斑狼疮和类风湿关节炎患者对水痘带状疱疹病毒的体液免疫
Vaccines (Basel). 2021 Apr 1;9(4):325. doi: 10.3390/vaccines9040325.
本文引用的文献
1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.奥瑞珠单抗与安慰剂治疗原发性进行性多发性硬化症。
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
2
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.奥瑞珠单抗与干扰素β-1a 治疗复发型多发性硬化症的疗效比较。
N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21.
3
Systemic lupus erythematosus: Extent and patterns of off-label use of rituximab for SLE.系统性红斑狼疮：利妥昔单抗在系统性红斑狼疮中未按药品说明书用药的范围和模式。
Nat Rev Rheumatol. 2016 Nov 22;12(12):700-702. doi: 10.1038/nrrheum.2016.191.
4
Lupus nephritis management guidelines compared.狼疮性肾炎管理指南比较。
Nephrol Dial Transplant. 2016 Jun;31(6):904-13. doi: 10.1093/ndt/gfv102. Epub 2015 Apr 28.
5
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).阿他西普预防中重度系统性红斑狼疮（SLE）患者病情复发的疗效和安全性：52周数据（APRIL-SLE随机试验）
Ann Rheum Dis. 2015 Nov;74(11):2006-15. doi: 10.1136/annrheumdis-2013-205067. Epub 2014 Jun 20.
6
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.阿巴西普在多发性硬化症中的研究（ATAMS）：一项随机、安慰剂对照、双盲、2 期临床试验。
Lancet Neurol. 2014 Apr;13(4):353-63. doi: 10.1016/S1474-4422(14)70028-6. Epub 2014 Mar 6.
7
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.MHC Ⅱ类依赖的 B 细胞 APC 功能对于诱导中枢神经系统自身免疫是必需的，而与髓鞘特异性抗体无关。
J Exp Med. 2013 Dec 16;210(13):2921-37. doi: 10.1084/jem.20130699. Epub 2013 Dec 9.
8
Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival.疟疾感染改变了 B 细胞激活因子的表达，导致记忆抗体反应减弱和存活能力降低。
Eur J Immunol. 2012 Dec;42(12):3291-301. doi: 10.1002/eji.201242689. Epub 2012 Oct 16.
9
Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection.乳糜泻风险基因座的进化和功能分析揭示 SH2B3 是抵抗细菌感染的保护因素。
Am J Hum Genet. 2010 Jun 11;86(6):970-7. doi: 10.1016/j.ajhg.2010.05.004.
10
Cracking the BAFF code.破解BAFF密码。
Nat Rev Immunol. 2009 Jul;9(7):491-502. doi: 10.1038/nri2572.
Zotero 插件